Recon: Metsera plunges after accepting Pfizer’s $10B offer; Eli Lilly partners with MeiraGTx's for eye disease gene therapy
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States